Photo of Elad Sharon from American Association for Cancer Research
Jun 21, 2024, 11:57
Elad Sharon: Two of my major trials led to FDA Oncology approvals
Elad Sharon, Clinical and Translational Director of Dana-Farber Cancer Institute, shared on X/Twitter:
“Past week, two of my major trials while I was at NCI CTEP Clinical Research led to FDA Oncology approvals… lots of effort from Amgen/ECOG-ACRIN Cancer Research Group team for E1910 and
Merck/NRG Oncology team for NRGgy018. Exciting to see these efforts come through for our patients!”
Source: Elad Sharon/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 13, 2024, 11:52
Nov 13, 2024, 11:48
Nov 13, 2024, 11:44
Nov 13, 2024, 11:39
Nov 13, 2024, 11:30
Nov 13, 2024, 11:25
Nov 13, 2024, 11:10
Nov 13, 2024, 10:59
Nov 13, 2024, 10:54